P436 Intravenous cyclophosphamide combined with thalidomide has a promising effect in refractory Crohn's disease.

MLA

Tang, J., et al. “P436 Intravenous Cyclophosphamide Combined with Thalidomide Has a Promising Effect in Refractory Crohn’s Disease.” Journal of Crohn’s & Colitis, vol. 8, Feb. 2014, pp. S247–48. EBSCOhost, https://doi.org/10.1016/S1873-9946(14)60556-0.

APA

Tang, J., Gao, X., Zhi, M., Zhou, H., Zhang, M., Chen, H., Yang, Q., & Liang, Z. (2014). P436 Intravenous cyclophosphamide combined with thalidomide has a promising effect in refractory Crohn’s disease. Journal of Crohn’s & Colitis, 8, S247–S248. https://doi.org/10.1016/S1873-9946(14)60556-0

Chicago

Tang, J., X. Gao, M. Zhi, H. Zhou, M. Zhang, H. Chen, Q. Yang, and Z. Liang. 2014. “P436 Intravenous Cyclophosphamide Combined with Thalidomide Has a Promising Effect in Refractory Crohn’s Disease.” Journal of Crohn’s & Colitis 8 (February): S247–48. doi:10.1016/S1873-9946(14)60556-0.